Our team serves as your medical partner and your cheerleader
Without that win, Novo Nordisk would have lacked leverage to negotiate a generic entry date after 2026, i.e., the expiration date for the other compound patent (122 patent.) It also bears asking why the 343 patent expires so much later than the 122 patent
doi: 10.1038/s41598-021-88612-x Liang L, Su X, Guan Y, Wu B, Zhang X, Nian X
Complete list of GLP-1 drugs available in 2026 Eleven GLP-1 receptor agonists are FDA-approved in the United States as of 2026, split across type 2 diabetes indications, chronic weight management indications, and in several cases both
The effect of retatrutide on kidney parameters in participants with type 2 diabetes and/or obesity
Sulfur-Rich Vegetables: Arugula, bok choy, broccoli, Brussels sprouts, cabbage, and cauliflower